Cholinesterase Inhibitor [EPC]

Cholinesterase Inhibitor [EPC] was reported 19111 times

Drugs of the Cholinesterase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MINI MENTAL STATUS EXAMINATION ABNORMAL 14 0.1707
1 MEDICAL DEVICE SITE DRYNESS 10 0.1538
2 VASCULAR ENCEPHALOPATHY 30 0.1056
3 URINARY CASTS PRESENT 11 0.1048
4 TOBACCO INTERACTION 11 0.0991
5 BLOOD CHOLINESTERASE DECREASED 27 0.0985
6 DEMENTIA ALZHEIMER'S TYPE 161 0.0964
7 STOMA SITE DISCOMFORT 21 0.0925
8 STOMA SITE INDURATION 11 0.0924
9 STOMA SITE REACTION 57 0.0832
10 STOMA SITE ERYTHEMA 146 0.0781
11 STOMA SITE DISCHARGE 191 0.0697
12 FREEZING PHENOMENON 257 0.0693
13 ON AND OFF PHENOMENON 381 0.0686
14 STOMA SITE ODOUR 15 0.0670
15 STOMA SITE IRRITATION 35 0.0643
16 DEMENTIA WITH LEWY BODIES 70 0.0629
17 STOMA SITE HYPERGRANULATION 38 0.0602
18 FIBROMA 55 0.0598
19 STOMA SITE INFLAMMATION 44 0.0589
20 AGNOSIA 14 0.0588
21 STOMA SITE EXTRAVASATION 22 0.0570
22 HYPERKINESIA 119 0.0561
23 ASPIRATION BRONCHIAL 16 0.0541
24 APPLICATION SITE HYPERSENSITIVITY 64 0.0527
25 CHOLINERGIC SYNDROME 32 0.0502
26 STOMA SITE PAIN 70 0.0476
27 EUTHANASIA 14 0.0442
28 ANTICHOLINERGIC SYNDROME 68 0.0427
29 REDUCED FACIAL EXPRESSION 43 0.0424
30 ENTERAL NUTRITION 23 0.0397
31 STOMA SITE INFECTION 51 0.0392
32 SENILE DEMENTIA 26 0.0390
33 BRADYKINESIA 221 0.0374
34 PARKINSONIAN GAIT 23 0.0369
35 AKINESIA 75 0.0362
36 PATIENT ELOPEMENT 11 0.0301
37 SUSPICIOUSNESS 21 0.0299
38 BASAL GANGLIA INFARCTION 10 0.0291
39 REPETITIVE SPEECH 16 0.0284
40 RESTING TREMOR 18 0.0279
41 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 28 0.0278
42 PLEUROTHOTONUS 25 0.0277
43 PARKINSON'S DISEASE 68 0.0267
44 FRONTOTEMPORAL DEMENTIA 11 0.0256
45 LACK OF SPONTANEOUS SPEECH 11 0.0251
46 MUSCLE RIGIDITY 295 0.0246
47 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 26 0.0242
48 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 10 0.0238
49 VASCULAR DEMENTIA 20 0.0228
50 STOMA SITE HAEMORRHAGE 33 0.0214
51 COGWHEEL RIGIDITY 22 0.0210
52 DEMENTIA 578 0.0207
53 GRIMACING 16 0.0205
54 CEREBELLAR ATROPHY 18 0.0204
55 DELUSION 316 0.0203
56 POSTURE ABNORMAL 66 0.0203
57 EYELID FUNCTION DISORDER 16 0.0202
58 SUBILEUS 42 0.0202
59 JOINT WARMTH 25 0.0200
60 HALLUCINATION 1482 0.0196
61 HALLUCINATION, VISUAL 413 0.0195
62 HALLUCINATION, TACTILE 13 0.0195
63 FOOD REFUSAL 17 0.0194
64 MEDICAL DEVICE CHANGE 10 0.0188
65 DEVICE ALARM ISSUE 31 0.0171
66 STOMA COMPLICATION 17 0.0167
67 COMPULSIONS 11 0.0165
68 ESCHAR 12 0.0164
69 NEURODEGENERATIVE DISORDER 10 0.0162
70 POLYPECTOMY 12 0.0150
71 THERAPEUTIC PRODUCT EFFECT VARIABLE 58 0.0149
72 DAYDREAMING 23 0.0149
73 PSYCHOTIC BEHAVIOUR 15 0.0148
74 HALLUCINATIONS, MIXED 62 0.0147
75 BLADDER CATHETERISATION 14 0.0144
76 DEVICE CONNECTION ISSUE 30 0.0142
77 APRAXIA 21 0.0142
78 HYPORESPONSIVE TO STIMULI 16 0.0136
79 CEREBRAL ATROPHY 54 0.0135
80 DELUSIONAL DISORDER, UNSPECIFIED TYPE 10 0.0134
81 ILLUSION 22 0.0133
82 APPLICATION SITE DERMATITIS 12 0.0128
83 PARKINSONISM 124 0.0127
84 SPUTUM INCREASED 27 0.0125
85 DYSCHEZIA 38 0.0124
86 COMMUNICATION DISORDER 45 0.0118
87 REHABILITATION THERAPY 44 0.0114
88 DYSKINESIA 456 0.0112
89 FLUID INTAKE REDUCED 56 0.0112
90 HYPERSEXUALITY 20 0.0109
91 INFUSION SITE INDURATION 16 0.0108
92 AGGRESSION 534 0.0107
93 SLEEP TALKING 18 0.0106
94 APPLICATION SITE ERYTHEMA 277 0.0106
95 TENSION 64 0.0105
96 INFUSION SITE NODULE 10 0.0104
97 NONSPECIFIC REACTION 57 0.0104
98 INFARCTION 70 0.0102
99 COGNITIVE DISORDER 476 0.0102
100 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 11 0.0100
101 FAECALOMA 54 0.0098
102 SALIVARY HYPERSECRETION 98 0.0098
103 GASTROSTOMY 15 0.0097
104 DYSENTERY 18 0.0097
105 INFREQUENT BOWEL MOVEMENTS 24 0.0096
106 SCREAMING 61 0.0096
107 SICK SINUS SYNDROME 11 0.0096
108 ABNORMAL BEHAVIOUR 376 0.0095
109 CLAVICLE FRACTURE 36 0.0094
110 APPLICATION SITE INFLAMMATION 13 0.0094
111 DELIRIUM 322 0.0093
112 TERMINAL STATE 62 0.0093
113 FEMORAL NECK FRACTURE 47 0.0092
114 INCOHERENT 59 0.0091
115 DEVICE KINK 33 0.0090
116 ORTHOSTATIC HYPOTENSION 156 0.0089
117 DISORIENTATION 355 0.0089
118 SINUS ARREST 14 0.0089
119 BLOOD SODIUM INCREASED 24 0.0089
120 HYPOKINESIA 128 0.0088
121 DECUBITUS ULCER 71 0.0087
122 CONCOMITANT DISEASE PROGRESSION 17 0.0087
123 APPLICATION SITE PRURITUS 197 0.0087
124 NOSOCOMIAL INFECTION 19 0.0086
125 TORTICOLLIS 18 0.0085
126 PRODUCT ADHESION ISSUE 299 0.0084
127 APPARENT DEATH 30 0.0083
128 PARANOIA 142 0.0082
129 CONFUSIONAL STATE 1331 0.0082
130 MOTOR DYSFUNCTION 81 0.0079
131 VITAMIN B12 DEFICIENCY 32 0.0079
132 PALLIATIVE CARE 12 0.0078
133 PSYCHOTIC SYMPTOM 16 0.0077
134 SLOW RESPONSE TO STIMULI 10 0.0077
135 APPLICATION SITE RASH 106 0.0077
136 RESTLESSNESS 281 0.0077
137 LOGORRHOEA 27 0.0077
138 FINE MOTOR SKILL DYSFUNCTION 22 0.0076
139 PNEUMONIA ASPIRATION 189 0.0076
140 AGITATION 553 0.0075
141 ASPIRATION 82 0.0075
142 LIVING IN RESIDENTIAL INSTITUTION 14 0.0075
143 WHITE BLOOD CELLS URINE POSITIVE 14 0.0074
144 WHEELCHAIR USER 33 0.0074
145 LANGUAGE DISORDER 16 0.0074
146 BRONCHOPNEUMONIA 25 0.0073
147 IMPAIRED SELF-CARE 15 0.0072
148 FACIAL BONES FRACTURE 26 0.0072
149 HYPOPHAGIA 182 0.0071
150 DROOLING 49 0.0071
151 FAECES HARD 27 0.0069
152 SPEECH DISORDER 363 0.0069
153 CARDIOACTIVE DRUG LEVEL INCREASED 9 0.0068
154 DISINHIBITION 11 0.0068
155 IMPULSE-CONTROL DISORDER 14 0.0068
156 DEVICE OCCLUSION 94 0.0067
157 CATATONIA 35 0.0067
158 GASTROINTESTINAL SOUNDS ABNORMAL 33 0.0067
159 ATRIOVENTRICULAR BLOCK SECOND DEGREE 20 0.0066
160 APPLICATION SITE REACTION 46 0.0065
161 SINUS BRADYCARDIA 63 0.0065
162 IMMOBILE 28 0.0064
163 GASTROINTESTINAL TUBE INSERTION 16 0.0064
164 DYSTONIA 123 0.0063
165 BEHAVIOUR DISORDER 34 0.0063
166 INCORRECT DOSE ADMINISTERED BY PRODUCT 10 0.0062
167 ABDOMINAL TENDERNESS 31 0.0062
168 MIOSIS 50 0.0062
169 HIP FRACTURE 200 0.0062
170 BEDRIDDEN 81 0.0062
171 PSYCHOMOTOR HYPERACTIVITY 101 0.0061
172 UNDERWEIGHT 12 0.0061
173 INCONTINENCE 64 0.0060
174 FAECAL INCONTINENCE 29 0.0060
175 HYPERNATRAEMIA 30 0.0060
176 APPLICATION SITE SWELLING 30 0.0060
177 PARADOXICAL DRUG REACTION 22 0.0060
178 NOCTURIA 72 0.0059
179 LIBIDO INCREASED 12 0.0059
180 MUSCLE CONTRACTURE 12 0.0059
181 PRODUCT SUPPLY ISSUE 42 0.0059
182 PARESIS 13 0.0058
183 CONCOMITANT DISEASE AGGRAVATED 36 0.0058
184 AUTONOMIC NERVOUS SYSTEM IMBALANCE 17 0.0058
185 UNRESPONSIVE TO STIMULI 148 0.0057
186 APHASIA 173 0.0057
187 URINARY INCONTINENCE 168 0.0057
188 RHINITIS ALLERGIC 25 0.0056
189 PERSECUTORY DELUSION 14 0.0056
190 STUPOR 18 0.0056
191 APPLICATION SITE VESICLES 36 0.0055
192 LABYRINTHITIS 14 0.0055
193 ABNORMAL DREAMS 152 0.0055
194 CLONUS 15 0.0055
195 BRADYARRHYTHMIA 9 0.0055
196 APPLICATION SITE IRRITATION 68 0.0055
197 ATRIOVENTRICULAR BLOCK 42 0.0054
198 CYTOLYTIC HEPATITIS 18 0.0054
199 HANGOVER 19 0.0054
200 NEUROLEPTIC MALIGNANT SYNDROME 64 0.0054
201 FALL 1793 0.0054
202 SPINAL COLUMN INJURY 12 0.0054
203 PSYCHOTIC DISORDER 159 0.0054
204 PRODUCT RESIDUE PRESENT 29 0.0054
205 ABNORMAL FAECES 44 0.0054
206 ABASIA 131 0.0053
207 BRADYCARDIA 281 0.0053
208 CRANIOCEREBRAL INJURY 16 0.0053
209 GENERAL PHYSICAL HEALTH DETERIORATION 580 0.0050
210 ANAL INCONTINENCE 45 0.0050
211 SLOW SPEECH 12 0.0049
212 APPLICATION SITE DISCOLOURATION 20 0.0049
213 MOBILITY DECREASED 352 0.0049
214 NASAL POLYPS 24 0.0049
215 CEREBRAL ISCHAEMIA 25 0.0049
216 DYSSTASIA 141 0.0048
217 APATHY 70 0.0048
218 APHAGIA 23 0.0048
219 WALKING DISABILITY 10 0.0048
220 POTENTIATING DRUG INTERACTION 16 0.0048
221 DYSPHAGIA 450 0.0047
222 MALNUTRITION 53 0.0047
223 INFUSION SITE INFECTION 11 0.0047
224 HEPATIC NEOPLASM MALIGNANT 10 0.0047
225 HEAD INJURY 149 0.0047
226 EATING DISORDER 99 0.0046
227 VOLVULUS 11 0.0046
228 ATROPHY 9 0.0046
229 BRADYPHRENIA 30 0.0046
230 BOWEL MOVEMENT IRREGULARITY 35 0.0046
231 HYPERSOMNIA 131 0.0046
232 STARING 11 0.0045
233 OBSESSIVE-COMPULSIVE DISORDER 36 0.0045
234 HALLUCINATION, AUDITORY 71 0.0045
235 CEREBRAL HAEMATOMA 15 0.0045
236 CORONARY ARTERY THROMBOSIS 9 0.0045
237 DIZZINESS POSTURAL 43 0.0044
238 APPETITE DISORDER 29 0.0044
239 MEMORY IMPAIRMENT 599 0.0044
240 FEMUR FRACTURE 135 0.0044
241 EXCORIATION 11 0.0043
242 ATRIOVENTRICULAR BLOCK COMPLETE 29 0.0043
243 GAIT INABILITY 144 0.0043
244 INCREASED BRONCHIAL SECRETION 11 0.0043
245 CACHEXIA 22 0.0043
246 HIP SURGERY 23 0.0042
247 LISTLESS 14 0.0042
248 BUNDLE BRANCH BLOCK LEFT 18 0.0042
249 OXYGEN SATURATION ABNORMAL 12 0.0042
250 ANAEMIA MACROCYTIC 9 0.0042
251 HEMIPLEGIA 35 0.0042
252 CATHETER SITE ERYTHEMA 9 0.0042
253 CHOKING 82 0.0042
254 PSYCHOMOTOR SKILLS IMPAIRED 11 0.0042
255 LACUNAR INFARCTION 10 0.0042
256 PEMPHIGOID 31 0.0041
257 ACCIDENTAL EXPOSURE 17 0.0041
258 PROSTATOMEGALY 16 0.0041
259 CARDIAC PACEMAKER INSERTION 24 0.0040
260 SKIN ABRASION 19 0.0040
261 SYNCOPE 402 0.0040
262 CREATININE RENAL CLEARANCE DECREASED 16 0.0040
263 WRONG PRODUCT ADMINISTERED 27 0.0040
264 MOVEMENT DISORDER 128 0.0040
265 COMPUTERISED TOMOGRAM ABNORMAL 9 0.0040
266 FEEDING DISORDER 80 0.0039
267 GAIT DISTURBANCE 753 0.0039
268 DIABETIC COMPLICATION 10 0.0039
269 MASTICATION DISORDER 12 0.0039
270 ISCHAEMIA 18 0.0039
271 DEVICE DISLOCATION 170 0.0039
272 MIDDLE INSOMNIA 73 0.0039
273 INITIAL INSOMNIA 40 0.0039
274 CEREBRAL THROMBOSIS 11 0.0039
275 BALANCE DISORDER 335 0.0039
276 DERMATITIS BULLOUS 28 0.0039
277 PELVIC FRACTURE 30 0.0038
278 HOSPICE CARE 38 0.0038
279 CARDIOPULMONARY FAILURE 15 0.0038
280 URINARY TRACT INFECTION 653 0.0038
281 MULTI-ORGAN FAILURE 66 0.0038
282 URINARY RETENTION 124 0.0037
283 HAEMORRHAGIC STROKE 29 0.0037
284 ILEUS 46 0.0037
285 INFUSION SITE REACTION 11 0.0037
286 TREMOR 610 0.0037
287 FAILURE TO THRIVE 19 0.0037
288 PRESCRIBED UNDERDOSE 73 0.0037
289 BLADDER DISORDER 36 0.0036
290 PANIC REACTION 26 0.0036
291 MEDICAL DEVICE DISCOMFORT 11 0.0036
292 ANOREXIA 46 0.0036
293 ELECTROCARDIOGRAM ABNORMAL 28 0.0036
294 DEPRESSED LEVEL OF CONSCIOUSNESS 140 0.0035
295 EMBEDDED DEVICE 35 0.0035
296 MYOCLONUS 42 0.0035
297 THERAPEUTIC PRODUCT EFFECT DELAYED 16 0.0035
298 DERMATITIS CONTACT 40 0.0035
299 WOUND COMPLICATION 12 0.0035
300 SUBDURAL HAEMATOMA 50 0.0035
301 CIRCULATORY COLLAPSE 59 0.0035
302 POLYMYALGIA RHEUMATICA 11 0.0035
303 SOMNOLENCE 694 0.0034
304 PRODUCT ADMINISTRATION INTERRUPTED 27 0.0034
305 CARDIO-RESPIRATORY ARREST 143 0.0034
306 MUSCLE CONTRACTIONS INVOLUNTARY 12 0.0034
307 NIGHTMARE 118 0.0034
308 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 162 0.0034
309 SEDATION 88 0.0034
310 PETIT MAL EPILEPSY 17 0.0033
311 HUMERUS FRACTURE 16 0.0033
312 BENIGN PROSTATIC HYPERPLASIA 17 0.0033
313 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 29 0.0033
314 FOOD INTOLERANCE 12 0.0033
315 GENERAL PHYSICAL CONDITION ABNORMAL 22 0.0032
316 TRANSIENT ISCHAEMIC ATTACK 108 0.0032
317 SOMNAMBULISM 21 0.0032
318 PALLOR 87 0.0032
319 HYDROCEPHALUS 17 0.0031
320 DUODENAL ULCER 22 0.0031
321 SOCIAL AVOIDANT BEHAVIOUR 18 0.0031
322 HYPOTONIA 31 0.0031
323 RALES 18 0.0031
324 MENTAL IMPAIRMENT 75 0.0031
325 DISTURBANCE IN ATTENTION 166 0.0031
326 BUNDLE BRANCH BLOCK RIGHT 14 0.0030
327 ALTERED STATE OF CONSCIOUSNESS 66 0.0030
328 SUSPECTED COVID-19 10 0.0030
329 RIB FRACTURE 62 0.0030
330 BLOOD PRESSURE FLUCTUATION 72 0.0030
331 HAEMATEMESIS 76 0.0030
332 DYSARTHRIA 112 0.0030
333 POOR QUALITY SLEEP 64 0.0030
334 ENURESIS 12 0.0030
335 HYPERTENSIVE CRISIS 33 0.0030
336 SUPRAVENTRICULAR EXTRASYSTOLES 10 0.0030
337 HYPERVENTILATION 17 0.0029
338 LOSS OF CONSCIOUSNESS 371 0.0029
339 MICTURITION DISORDER 10 0.0029
340 DEFAECATION URGENCY 20 0.0029
341 EPILEPSY 87 0.0028
342 PANIC DISORDER 11 0.0028
343 ESCHERICHIA URINARY TRACT INFECTION 12 0.0028
344 HYPERTONIA 16 0.0028
345 DEVICE PLACEMENT ISSUE 10 0.0028
346 EXTRAPYRAMIDAL DISORDER 69 0.0028
347 EYE MOVEMENT DISORDER 19 0.0028
348 MUSCULOSKELETAL STIFFNESS 243 0.0028
349 ATRIOVENTRICULAR BLOCK FIRST DEGREE 12 0.0028
350 DEHYDRATION 369 0.0028
351 CARDIOMEGALY 34 0.0028
352 WRONG TECHNIQUE IN DRUG USAGE PROCESS 100 0.0027
353 FEAR 74 0.0027
354 LYMPHOEDEMA 19 0.0027
355 SUDDEN DEATH 29 0.0027
356 CEREBRAL HAEMORRHAGE 98 0.0027
357 DYSGRAPHIA 18 0.0027
358 HAEMORRHAGIC ANAEMIA 12 0.0027
359 DEATH 2339 0.0027
360 VARICOSE VEIN 14 0.0027
361 UROSEPSIS 25 0.0027
362 CEREBROVASCULAR ACCIDENT 456 0.0027
363 PARTIAL SEIZURES 14 0.0027
364 IMPULSIVE BEHAVIOUR 10 0.0027
365 ARRHYTHMIA 125 0.0026
366 BODY HEIGHT DECREASED 28 0.0026
367 GASTROINTESTINAL MOTILITY DISORDER 14 0.0026
368 SLEEP TERROR 11 0.0026
369 RESPIRATORY ARREST 71 0.0026
370 BLOOD UREA INCREASED 43 0.0026
371 AMNESIA 167 0.0026
372 LOWER LIMB FRACTURE 49 0.0025
373 DRUG INTERACTION 404 0.0025
374 UNEVALUABLE EVENT 192 0.0025
375 CARDIAC ARREST 209 0.0025
376 TEMPERATURE INTOLERANCE 26 0.0025
377 PARALYSIS 36 0.0025
378 INTERNATIONAL NORMALISED RATIO INCREASED 70 0.0025
379 COORDINATION ABNORMAL 34 0.0024
380 WALKING AID USER 16 0.0024
381 PRODUCT ADMINISTRATION ERROR 49 0.0024
382 WRIST FRACTURE 29 0.0024
383 AKATHISIA 33 0.0024
384 CEREBRAL INFARCTION 59 0.0024
385 HAND FRACTURE 17 0.0024
386 WHITE BLOOD CELL COUNT INCREASED 92 0.0024
387 ANGER 81 0.0024
388 NEPHROGENIC ANAEMIA 11 0.0024
389 INFUSION SITE ERYTHEMA 20 0.0024
390 SLEEP DISORDER 166 0.0023
391 NEUTROPHIL COUNT INCREASED 24 0.0023
392 PURULENT DISCHARGE 10 0.0023
393 DEVICE ISSUE 209 0.0023
394 ACTIVITIES OF DAILY LIVING IMPAIRED 46 0.0023
395 LEUKOCYTOSIS 42 0.0023
396 LUNG INFECTION 36 0.0023
397 CONVULSION 132 0.0023
398 MENTAL STATUS CHANGES 64 0.0023
399 PSYCHIATRIC SYMPTOM 17 0.0023
400 SKIN LACERATION 25 0.0023
401 DYSPHEMIA 10 0.0023
402 LETHARGY 131 0.0023
403 GRAND MAL CONVULSION 21 0.0023
404 HYPOTHERMIA 23 0.0023
405 SOPOR 30 0.0023
406 GASTRIC ULCER 43 0.0023
407 THINKING ABNORMAL 42 0.0023
408 PNEUMONIA 729 0.0022
409 APPLICATION SITE BURN 11 0.0022
410 GASTROINTESTINAL INFECTION 20 0.0022
411 HYPONATRAEMIA 125 0.0022
412 VENTRICULAR EXTRASYSTOLES 23 0.0022
413 BLOOD PRESSURE DECREASED 147 0.0022
414 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 157 0.0022
415 DECREASED APPETITE 512 0.0022
416 SKIN REACTION 31 0.0022
417 HEART RATE DECREASED 77 0.0022
418 ERYSIPELAS 11 0.0022
419 MANIA 36 0.0022
420 APPLICATION SITE EXFOLIATION 9 0.0022
421 TOXIC SKIN ERUPTION 22 0.0022
422 APNOEA 17 0.0022
423 JOINT DISLOCATION 23 0.0022
424 PROSTATIC DISORDER 12 0.0022
425 DRUG TOLERANCE 11 0.0022
426 C-REACTIVE PROTEIN INCREASED 79 0.0022
427 TORSADE DE POINTES 17 0.0022
428 GASTRIC ULCER HAEMORRHAGE 12 0.0022
429 HIATUS HERNIA 28 0.0022
430 CONDITION AGGRAVATED 656 0.0022
431 WEIGHT DECREASED 602 0.0022
432 DECREASED ACTIVITY 23 0.0021
433 RECTAL HAEMORRHAGE 91 0.0021
434 RESPIRATORY TRACT INFECTION 55 0.0021
435 COLD SWEAT 37 0.0021
436 DEVICE PHYSICAL PROPERTY ISSUE 16 0.0021
437 APPLICATION SITE PAIN 46 0.0021
438 HYPOTENSION 414 0.0021
439 BLOOD PRESSURE ABNORMAL 41 0.0021
440 DEPRESSED MOOD 108 0.0020
441 PERIPHERAL COLDNESS 28 0.0020
442 STATUS EPILEPTICUS 23 0.0020
443 LOWER GASTROINTESTINAL HAEMORRHAGE 15 0.0020
444 COMA 96 0.0020
445 HEMIPARESIS 34 0.0020
446 HAEMATOMA 52 0.0020
447 GASTROENTERITIS 29 0.0020
448 PRODUCT AVAILABILITY ISSUE 45 0.0020
449 GASTRITIS 52 0.0020
450 CORONAVIRUS INFECTION 13 0.0020
451 VOMITING 922 0.0020
452 ACUTE PULMONARY OEDEMA 11 0.0020
453 MENTAL DISORDER 85 0.0020
454 RESPIRATORY FAILURE 142 0.0019
455 MITRAL VALVE INCOMPETENCE 22 0.0019
456 PERONEAL NERVE PALSY 11 0.0019
457 PURPURA 17 0.0019
458 ARTERIOSCLEROSIS 18 0.0019
459 GASTRIC HAEMORRHAGE 22 0.0019
460 UPPER LIMB FRACTURE 38 0.0019
461 INFUSION SITE SWELLING 12 0.0019
462 CARDIAC FAILURE 153 0.0019
463 UNINTENTIONAL MEDICAL DEVICE REMOVAL 22 0.0019
464 CYSTITIS 60 0.0019
465 CRYING 68 0.0019
466 RENAL FAILURE ACUTE 79 0.0019
467 CONSTIPATION 405 0.0019
468 CATARACT OPERATION 11 0.0019
469 PROTHROMBIN TIME PROLONGED 11 0.0018
470 RETCHING 39 0.0018
471 BLOOD PRESSURE INADEQUATELY CONTROLLED 11 0.0018
472 IMPAIRED QUALITY OF LIFE 26 0.0018
473 ANEURYSM 9 0.0018
474 LACERATION 17 0.0018
475 SCRATCH 19 0.0018
476 UPPER GASTROINTESTINAL HAEMORRHAGE 30 0.0018
477 NERVOUSNESS 93 0.0018
478 HEART RATE IRREGULAR 40 0.0018
479 REBOUND EFFECT 20 0.0018
480 MEDICATION ERROR 98 0.0018
481 MOOD ALTERED 48 0.0018
482 MUSCULAR WEAKNESS 200 0.0018
483 ATELECTASIS 17 0.0018
484 CEREBRAL DISORDER 13 0.0018
485 INSOMNIA 468 0.0018
486 SECRETION DISCHARGE 22 0.0018
487 HEAD DISCOMFORT 31 0.0017
488 BLOOD PRESSURE SYSTOLIC INCREASED 34 0.0017
489 PRESYNCOPE 42 0.0017
490 ELECTROCARDIOGRAM QT PROLONGED 62 0.0017
491 ASTHENIA 644 0.0017
492 HYPOVOLAEMIA 10 0.0017
493 HYPERTHERMIA 13 0.0017
494 URINE ODOUR ABNORMAL 10 0.0017
495 GASTROINTESTINAL HAEMORRHAGE 142 0.0017
496 UNDERDOSE 124 0.0017
497 LIPASE INCREASED 13 0.0017
498 TACHYPNOEA 23 0.0017
499 FRACTURE 32 0.0017
500 EMBOLISM 14 0.0017
501 REFUSAL OF TREATMENT BY PATIENT 11 0.0017
502 SKIN IRRITATION 77 0.0017
503 POLLAKIURIA 70 0.0017
504 DERMATITIS ALLERGIC 21 0.0017
505 SLUGGISHNESS 17 0.0017
506 AFFECTIVE DISORDER 13 0.0017
507 CYANOSIS 26 0.0017
508 DIZZINESS 821 0.0016
509 WOUND 46 0.0016
510 MELAENA 36 0.0016
511 ELECTROLYTE IMBALANCE 19 0.0016
512 ATRIAL FLUTTER 13 0.0016
513 DRUG ADMINISTRATION ERROR 50 0.0016
514 HYPERKALAEMIA 57 0.0016
515 BODY TEMPERATURE DECREASED 16 0.0016
516 FOOT DEFORMITY 18 0.0016
517 HYPERHIDROSIS 209 0.0016
518 PERSONALITY CHANGE 15 0.0016
519 FAECES DISCOLOURED 35 0.0016
520 BLOOD CREATINE PHOSPHOKINASE INCREASED 46 0.0016
521 RESTLESS LEGS SYNDROME 29 0.0016
522 JOINT INJURY 34 0.0016
523 BLOOD SODIUM DECREASED 30 0.0016
524 EMPHYSEMA 16 0.0016
525 HICCUPS 13 0.0016
526 TROPONIN INCREASED 12 0.0016
527 PRODUCTIVE COUGH 75 0.0016
528 HAEMATOCRIT DECREASED 31 0.0016
529 DRUG INTOLERANCE 151 0.0016
530 MUSCLE TWITCHING 36 0.0016
531 MALAISE 681 0.0016
532 WOUND INFECTION 17 0.0016
533 DEVICE USE ISSUE 27 0.0015
534 OSTEOARTHRITIS 65 0.0015
535 HYPERTENSION 324 0.0015
536 DECREASED INTEREST 9 0.0015
537 FACIAL PARALYSIS 13 0.0015
538 PHOTOSENSITIVITY REACTION 25 0.0015
539 BLOOD ALBUMIN DECREASED 12 0.0015
540 PRODUCT PRESCRIBING ERROR 36 0.0015
541 INTENTIONAL UNDERDOSE 11 0.0015
542 ATRIAL FIBRILLATION 146 0.0015
543 SPINAL FRACTURE 30 0.0015
544 MICTURITION URGENCY 17 0.0015
545 URINE OUTPUT DECREASED 13 0.0015
546 OEDEMA PERIPHERAL 180 0.0015
547 CHROMATURIA 33 0.0015
548 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15 0.0015
549 ISCHAEMIC STROKE 26 0.0015
550 SEXUAL DYSFUNCTION 17 0.0014
551 THERAPEUTIC RESPONSE SHORTENED 48 0.0014
552 IRRITABILITY 87 0.0014
553 AORTIC ANEURYSM 11 0.0014
554 GAMMA-GLUTAMYLTRANSFERASE INCREASED 32 0.0014
555 HYPOGLYCAEMIA 70 0.0014
556 ANXIETY 408 0.0014
557 ACCIDENT 17 0.0014
558 PANCREATITIS 75 0.0014
559 APHTHOUS ULCER 11 0.0014
560 DIABETES MELLITUS 108 0.0014
561 RHABDOMYOLYSIS 59 0.0014
562 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
563 THERMAL BURN 10 0.0014
564 IRON DEFICIENCY ANAEMIA 13 0.0014
565 LUNG DISORDER 69 0.0014
566 PRESCRIBED OVERDOSE 27 0.0014
567 ULCER 22 0.0014
568 HYPERCALCAEMIA 17 0.0014
569 OESOPHAGITIS 15 0.0014
570 SEPSIS 153 0.0014
571 SENSORY DISTURBANCE 22 0.0014
572 LUNG INFILTRATION 12 0.0014
573 MUSCLE DISORDER 11 0.0014
574 DEPRESSION 309 0.0014
575 BRAIN OEDEMA 17 0.0013
576 SEIZURE 155 0.0013
577 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 23 0.0013
578 THERAPEUTIC PRODUCT EFFECT DECREASED 60 0.0013
579 ACCIDENTAL OVERDOSE 49 0.0013
580 DEAFNESS 35 0.0013
581 GENERAL SYMPTOM 10 0.0013
582 DYSPHONIA 78 0.0013
583 SEPTIC SHOCK 58 0.0013
584 SPINAL COMPRESSION FRACTURE 11 0.0013
585 ACUTE MYOCARDIAL INFARCTION 39 0.0013
586 MOOD SWINGS 42 0.0013
587 FEELING ABNORMAL 315 0.0013
588 ANOSMIA 19 0.0013
589 RENAL FAILURE CHRONIC 10 0.0013
590 ACUTE RESPIRATORY FAILURE 25 0.0013
591 HYPOALBUMINAEMIA 10 0.0013
592 POISONING 16 0.0013
593 CARDIAC DISORDER 119 0.0013
594 QUALITY OF LIFE DECREASED 17 0.0013
595 RENAL FAILURE 168 0.0013
596 BLISTER 71 0.0013
597 BLOOD POTASSIUM DECREASED 38 0.0013
598 RENAL CYST 10 0.0013
599 BLOOD PRESSURE INCREASED 192 0.0013
600 BLOOD CALCIUM INCREASED 11 0.0013
601 PULMONARY OEDEMA 56 0.0012
602 GASTROINTESTINAL DISORDER 112 0.0012
603 LACTIC ACIDOSIS 40 0.0012
604 SCHIZOPHRENIA 15 0.0012
605 PULMONARY EMBOLISM 117 0.0012
606 SHOCK HAEMORRHAGIC 10 0.0012
607 ASPHYXIA 10 0.0012
608 ENCEPHALOPATHY 30 0.0012
609 NERVOUS SYSTEM DISORDER 38 0.0012
610 SKIN HAEMORRHAGE 18 0.0012
611 HEPATITIS 31 0.0012
612 BLOOD CREATININE INCREASED 79 0.0012
613 BLOOD ALKALINE PHOSPHATASE INCREASED 30 0.0012
614 EOSINOPHIL COUNT INCREASED 10 0.0012
615 CHOLESTASIS 23 0.0012
616 BACK INJURY 13 0.0012
617 GASTRIC DISORDER 41 0.0012
618 DIPLOPIA 31 0.0012
619 CHOLELITHIASIS 39 0.0012
620 BLOOD IRON DECREASED 14 0.0012
621 HIP ARTHROPLASTY 18 0.0012
622 ANAEMIA 224 0.0012
623 MACULAR DEGENERATION 14 0.0012
624 RESPIRATORY DISORDER 35 0.0012
625 MULTIPLE ORGAN DYSFUNCTION SYNDROME 33 0.0012
626 CONCUSSION 9 0.0012
627 CARDIAC MURMUR 10 0.0012
628 DIVERTICULITIS 32 0.0012
629 PYELONEPHRITIS 10 0.0012
630 SLEEP APNOEA SYNDROME 22 0.0012
631 DRUG PRESCRIBING ERROR 22 0.0011
632 COLON CANCER 17 0.0011
633 INFECTION 165 0.0011
634 THERAPEUTIC RESPONSE UNEXPECTED 51 0.0011
635 VITAMIN D DEFICIENCY 11 0.0011
636 RESPIRATORY RATE INCREASED 10 0.0011
637 MYOCARDIAL INFARCTION 196 0.0011
638 INTESTINAL OBSTRUCTION 42 0.0011
639 DYSURIA 41 0.0011
640 PANCREATITIS ACUTE 25 0.0011
641 BLOOD POTASSIUM INCREASED 18 0.0011
642 DEVICE BREAKAGE 45 0.0011
643 BLOOD URINE PRESENT 21 0.0011
644 LIMB INJURY 30 0.0011
645 BIPOLAR DISORDER 12 0.0011
646 MUSCULOSKELETAL DISORDER 21 0.0011
647 NAUSEA 873 0.0011
648 DRUG TOXICITY 15 0.0011
649 SKIN DISCOLOURATION 50 0.0011
650 RESPIRATORY DISTRESS 30 0.0011
651 ACUTE CORONARY SYNDROME 9 0.0011
652 PRODUCT USE COMPLAINT 17 0.0011
653 EUPHORIC MOOD 11 0.0011
654 EMOTIONAL DISORDER 33 0.0011
655 KIDNEY INFECTION 21 0.0011
656 CONTUSION 103 0.0011
657 OXYGEN SATURATION DECREASED 60 0.0011
658 CARDIOVASCULAR DISORDER 27 0.0011
659 SQUAMOUS CELL CARCINOMA 10 0.0011
660 CATARACT 63 0.0011
661 SINUS TACHYCARDIA 15 0.0011
662 SPUTUM DISCOLOURED 10 0.0011
663 RENAL DISORDER 49 0.0011
664 WEIGHT FLUCTUATION 11 0.0011
665 DISEASE PROGRESSION 124 0.0010
666 ADVERSE DRUG REACTION 94 0.0010
667 JAUNDICE 28 0.0010
668 HYPOKALAEMIA 48 0.0010
669 DIARRHOEA 670 0.0010
670 LIMB DISCOMFORT 32 0.0010
671 VERTIGO 63 0.0010
672 ACUTE KIDNEY INJURY 158 0.0010
673 MUSCLE ATROPHY 13 0.0010
674 SKIN LESION 28 0.0010
675 DIABETES MELLITUS INADEQUATE CONTROL 18 0.0010
676 HYPERGLYCAEMIA 37 0.0010
677 MYDRIASIS 13 0.0010
678 ERYTHEMA 208 0.0010
679 ATAXIA 12 0.0010
680 CARDIAC FAILURE CONGESTIVE 81 0.0010
681 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
682 BLOOD GLUCOSE FLUCTUATION 11 0.0010
683 HAEMORRHAGE INTRACRANIAL 15 0.0010
684 ABDOMINAL PAIN 233 0.0010
685 TOOTH FRACTURE 11 0.0010
686 DEVICE DIFFICULT TO USE 66 0.0010
687 OSTEOPOROSIS 41 0.0010
688 ABDOMINAL DISTENSION 104 0.0010
689 HYPOXIA 35 0.0010
690 HAEMOGLOBIN DECREASED 102 0.0010
691 TASTE DISORDER 20 0.0010
692 ORAL PAIN 22 0.0010
693 BODY TEMPERATURE INCREASED 20 0.0010
694 PERIPHERAL SWELLING 151 0.0010
695 VENTRICULAR TACHYCARDIA 16 0.0010
696 AGRANULOCYTOSIS 18 0.0010
697 MYELODYSPLASTIC SYNDROME 14 0.0010
698 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
699 CARDIOMYOPATHY 14 0.0009
700 DEVICE LEAKAGE 41 0.0009
701 TRANSAMINASES INCREASED 21 0.0009
702 PRODUCT DOSE OMISSION ISSUE 276 0.0009
703 PLEURAL EFFUSION 57 0.0009
704 CHOLECYSTITIS 11 0.0009
705 OSTEOPENIA 14 0.0009
706 DEVICE USE ERROR 32 0.0009
707 HYPERLIPIDAEMIA 11 0.0009
708 NODULE 12 0.0009
709 POLYNEUROPATHY 11 0.0009
710 HEPATOCELLULAR INJURY 13 0.0009
711 EOSINOPHILIA 16 0.0009
712 INFLAMMATION 47 0.0009
713 PULMONARY CONGESTION 12 0.0009
714 GASTROINTESTINAL PAIN 10 0.0009
715 DERMATITIS 19 0.0009
716 CARDIOGENIC SHOCK 13 0.0009
717 HAEMATURIA 31 0.0009
718 TACHYCARDIA 80 0.0009
719 PYREXIA 311 0.0009
720 PRODUCT PHYSICAL ISSUE 18 0.0009
721 EPISTAXIS 66 0.0009
722 FATIGUE 686 0.0009
723 IMPAIRED GASTRIC EMPTYING 12 0.0009
724 HERNIA 17 0.0009
725 MUSCLE SPASMS 161 0.0009
726 SCAB 10 0.0009
727 SCAR 15 0.0009
728 INTERNAL HAEMORRHAGE 10 0.0009
729 SHOCK 20 0.0009
730 HYPOACUSIS 37 0.0009
731 RASH MACULO-PAPULAR 19 0.0009
732 INFUSION SITE PAIN 11 0.0009
733 FLATULENCE 48 0.0008
734 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 171 0.0008
735 ABDOMINAL DISCOMFORT 141 0.0008
736 HAND DEFORMITY 11 0.0008
737 DRY MOUTH 68 0.0008
738 WITHDRAWAL SYNDROME 35 0.0008
739 TREATMENT NONCOMPLIANCE 45 0.0008
740 PRODUCT USE IN UNAPPROVED INDICATION 203 0.0008
741 HAEMATOCHEZIA 45 0.0008
742 FUNGAL INFECTION 27 0.0008
743 BACTERIAL INFECTION 15 0.0008
744 PRODUCT SUBSTITUTION ISSUE 46 0.0008
745 LYMPHOCYTE COUNT DECREASED 14 0.0008
746 MULTIPLE FRACTURES 13 0.0008
747 ASPARTATE AMINOTRANSFERASE INCREASED 42 0.0008
748 FEELING COLD 22 0.0008
749 ILL-DEFINED DISORDER 48 0.0008
750 OVERDOSE 170 0.0008
751 NECK PAIN 44 0.0008
752 INCREASED APPETITE 15 0.0008
753 GALLBLADDER DISORDER 14 0.0008
754 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 43 0.0008
755 VIRAL INFECTION 26 0.0008
756 HOSPITALISATION 120 0.0008
757 SKIN DISORDER 26 0.0008
758 GLAUCOMA 15 0.0008
759 RASH MACULAR 27 0.0008
760 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 40 0.0008
761 COMPLICATION ASSOCIATED WITH DEVICE 11 0.0008
762 DYSPNOEA 426 0.0008
763 CHEST PAIN 139 0.0007
764 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 35 0.0007
765 TOXICITY TO VARIOUS AGENTS 126 0.0007
766 COVID-19 131 0.0007
767 JOINT RANGE OF MOTION DECREASED 10 0.0007
768 HEPATIC CIRRHOSIS 14 0.0007
769 DRUG INEFFECTIVE 980 0.0007
770 BRONCHITIS 55 0.0007
771 PRODUCT DOSE OMISSION IN ERROR 21 0.0007
772 PRURITUS GENERALISED 16 0.0007
773 BACK DISORDER 12 0.0007
774 SURGERY 43 0.0007
775 PANCREATIC CARCINOMA 21 0.0007
776 DRUG LEVEL INCREASED 12 0.0007
777 DRUG DISPENSING ERROR 11 0.0007
778 STEVENS-JOHNSON SYNDROME 16 0.0007
779 NEPHROLITHIASIS 33 0.0007
780 EXTRA DOSE ADMINISTERED 29 0.0007
781 MASS 10 0.0007
782 RASH PAPULAR 16 0.0007
783 HYPERSENSITIVITY 132 0.0007
784 MUSCULOSKELETAL CHEST PAIN 11 0.0007
785 ANKLE FRACTURE 11 0.0007
786 THROMBOSIS 57 0.0007
787 THERAPY PARTIAL RESPONDER 11 0.0007
788 ABDOMINAL PAIN UPPER 145 0.0007
789 FREQUENT BOWEL MOVEMENTS 19 0.0007
790 DYSPEPSIA 69 0.0007
791 OEDEMA 38 0.0007
792 ANGINA PECTORIS 20 0.0007
793 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
794 PRODUCT DOSE OMISSION 45 0.0007
795 ILLNESS 71 0.0007
796 HYPOTHYROIDISM 22 0.0007
797 THROMBOCYTOPENIA 77 0.0007
798 FOOT FRACTURE 13 0.0007
799 PRODUCT USE ISSUE 128 0.0007
800 HAEMORRHAGE 71 0.0007
801 SEROTONIN SYNDROME 13 0.0007
802 CELLULITIS 34 0.0007
803 NEOPLASM MALIGNANT 45 0.0007
804 INJURY 47 0.0007
805 SUICIDAL IDEATION 61 0.0007
806 OSTEOMYELITIS 12 0.0007
807 OFF LABEL USE 580 0.0007
808 CORONARY ARTERY DISEASE 20 0.0007
809 COAGULOPATHY 11 0.0007
810 END STAGE RENAL DISEASE 12 0.0007
811 SKIN ULCER 17 0.0007
812 METABOLIC ACIDOSIS 21 0.0007
813 RASH GENERALISED 17 0.0007
814 DISCOMFORT 40 0.0007
815 LIVER FUNCTION TEST ABNORMAL 19 0.0007
816 PRURITUS 251 0.0007
817 FACE OEDEMA 11 0.0007
818 DEVICE RELATED INFECTION 10 0.0006
819 RASH ERYTHEMATOUS 31 0.0006
820 BLOOD TEST ABNORMAL 9 0.0006
821 IMPAIRED HEALING 21 0.0006
822 INCORRECT DOSE ADMINISTERED 146 0.0006
823 BLINDNESS UNILATERAL 9 0.0006
824 ALANINE AMINOTRANSFERASE INCREASED 39 0.0006
825 LIVER DISORDER 28 0.0006
826 TINNITUS 29 0.0006
827 LACRIMATION INCREASED 19 0.0006
828 PAIN IN EXTREMITY 184 0.0006
829 BLOOD CHOLESTEROL INCREASED 29 0.0006
830 DRUG ERUPTION 11 0.0006
831 ERUCTATION 12 0.0006
832 MUSCLE TIGHTNESS 10 0.0006
833 LOWER RESPIRATORY TRACT INFECTION 28 0.0006
834 CHILLS 72 0.0006
835 VISUAL IMPAIRMENT 76 0.0006
836 ANGIOEDEMA 27 0.0006
837 GASTROENTERITIS VIRAL 11 0.0006
838 SWOLLEN TONGUE 19 0.0006
839 EYE DISORDER 20 0.0006
840 RENAL IMPAIRMENT 51 0.0006
841 HEART RATE INCREASED 60 0.0006
842 SKIN CANCER 13 0.0006
843 BONE DISORDER 11 0.0006
844 PANIC ATTACK 22 0.0006
845 ASTHMA 68 0.0006
846 NASAL CONGESTION 35 0.0006
847 CONJUNCTIVITIS 11 0.0006
848 INFLUENZA 66 0.0006
849 FLUID RETENTION 30 0.0006
850 JOINT SWELLING 71 0.0006
851 RHINORRHOEA 38 0.0006
852 DEEP VEIN THROMBOSIS 38 0.0006
853 WEIGHT INCREASED 130 0.0006
854 PERITONITIS 12 0.0006
855 THERAPY NON-RESPONDER 26 0.0006
856 FEELING JITTERY 11 0.0006
857 BASAL CELL CARCINOMA 9 0.0006
858 BACK PAIN 134 0.0006
859 LOCAL SWELLING 10 0.0006
860 INCORRECT DRUG ADMINISTRATION DURATION 16 0.0006
861 COUGH 159 0.0006
862 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 102 0.0006
863 THERAPY CESSATION 29 0.0006
864 BLINDNESS 23 0.0006
865 TYPE 2 DIABETES MELLITUS 19 0.0006
866 HAEMORRHOIDS 11 0.0006
867 LEUKOPENIA 28 0.0006
868 COLITIS 21 0.0006
869 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
870 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 10 0.0005
871 RASH 235 0.0005
872 SWELLING FACE 35 0.0005
873 INTERSTITIAL LUNG DISEASE 26 0.0005
874 LUNG NEOPLASM MALIGNANT 22 0.0005
875 ARTHRITIS 42 0.0005
876 NIGHT SWEATS 17 0.0005
877 CHRONIC KIDNEY DISEASE 40 0.0005
878 RED BLOOD CELL COUNT DECREASED 15 0.0005
879 PULMONARY FIBROSIS 10 0.0005
880 AGEUSIA 13 0.0005
881 POST PROCEDURAL COMPLICATION 10 0.0005
882 PERICARDIAL EFFUSION 12 0.0005
883 RASH PRURITIC 28 0.0005
884 PARAESTHESIA 81 0.0005
885 SWELLING 48 0.0005
886 PAIN 313 0.0005
887 WHEEZING 30 0.0005
888 NASOPHARYNGITIS 92 0.0005
889 NO ADVERSE EVENT 90 0.0005
890 LOCALISED INFECTION 12 0.0005
891 HEADACHE 310 0.0005
892 NEURALGIA 12 0.0005
893 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 35 0.0005
894 GASTROOESOPHAGEAL REFLUX DISEASE 39 0.0005
895 TOOTH LOSS 10 0.0005
896 BLOOD BILIRUBIN INCREASED 13 0.0005
897 GASTRIC CANCER 12 0.0005
898 BURNING SENSATION 33 0.0005
899 HERPES ZOSTER 27 0.0005
900 DRUG EFFECT INCOMPLETE 17 0.0005
901 INTENTIONAL OVERDOSE 30 0.0005
902 PRODUCT DISPENSING ERROR 10 0.0005
903 PRODUCT PRESCRIBING ISSUE 10 0.0005
904 HYPOAESTHESIA 68 0.0005
905 ROAD TRAFFIC ACCIDENT 19 0.0005
906 TOOTH DISORDER 10 0.0004
907 BLOOD GLUCOSE INCREASED 83 0.0004
908 MUSCULOSKELETAL PAIN 23 0.0004
909 SKIN EXFOLIATION 37 0.0004
910 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
911 HAEMOPTYSIS 12 0.0004
912 HEPATIC ENZYME INCREASED 29 0.0004
913 ECZEMA 22 0.0004
914 BLOOD GLUCOSE DECREASED 20 0.0004
915 URTICARIA 69 0.0004
916 CONTRAINDICATED PRODUCT ADMINISTERED 12 0.0004
917 ARTHROPATHY 22 0.0004
918 STAPHYLOCOCCAL INFECTION 13 0.0004
919 INCORRECT ROUTE OF DRUG ADMINISTRATION 14 0.0004
920 CHEST DISCOMFORT 40 0.0004
921 DRUG RESISTANCE 10 0.0004
922 INTENTIONAL DOSE OMISSION 11 0.0004
923 DRUG-INDUCED LIVER INJURY 12 0.0004
924 INCORRECT DOSE ADMINISTERED BY DEVICE 10 0.0004
925 THERAPEUTIC RESPONSE DECREASED 23 0.0004
926 THERAPY INTERRUPTED 27 0.0004
927 LABORATORY TEST ABNORMAL 11 0.0004
928 THROAT TIGHTNESS 10 0.0004
929 PALPITATIONS 43 0.0004
930 DRUG DOSE OMISSION 60 0.0004
931 VISUAL ACUITY REDUCED 12 0.0004
932 TARDIVE DYSKINESIA 10 0.0004
933 HEPATIC FUNCTION ABNORMAL 13 0.0003
934 PLATELET COUNT DECREASED 37 0.0003
935 PANCYTOPENIA 19 0.0003
936 OCULAR HYPERAEMIA 16 0.0003
937 RENAL INJURY 10 0.0003
938 VISION BLURRED 46 0.0003
939 MULTIPLE SCLEROSIS 16 0.0003
940 THROAT IRRITATION 15 0.0003
941 EXPIRED PRODUCT ADMINISTERED 11 0.0003
942 ARTHRALGIA 137 0.0003
943 INFLUENZA LIKE ILLNESS 27 0.0003
944 FEELING HOT 20 0.0003
945 NEUROPATHY PERIPHERAL 31 0.0003
946 DRY SKIN 43 0.0003
947 DYSPNOEA EXERTIONAL 12 0.0003
948 DRUG EFFECT DECREASED 17 0.0003
949 ADVERSE EVENT 29 0.0003
950 SUICIDE ATTEMPT 19 0.0003
951 PROSTATE CANCER 25 0.0003
952 EMOTIONAL DISTRESS 37 0.0003
953 COMPLETED SUICIDE 25 0.0003
954 EYE SWELLING 11 0.0003
955 MIGRAINE 28 0.0003
956 BONE PAIN 17 0.0003
957 BONE DENSITY DECREASED 9 0.0003
958 STOMATITIS 17 0.0003
959 PRODUCT QUALITY ISSUE 38 0.0003
960 DISEASE RECURRENCE 13 0.0003
961 INFUSION RELATED REACTION 18 0.0003
962 WHITE BLOOD CELL COUNT DECREASED 28 0.0003
963 BREAST CANCER 24 0.0003
964 INTENTIONAL PRODUCT MISUSE 21 0.0002
965 VAGINAL HAEMORRHAGE 10 0.0002
966 DYSGEUSIA 17 0.0002
967 OROPHARYNGEAL PAIN 21 0.0002
968 HOT FLUSH 17 0.0002
969 SINUSITIS 23 0.0002
970 COLITIS ULCERATIVE 10 0.0002
971 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
972 FLUSHING 22 0.0002
973 EYE PAIN 12 0.0002
974 MYALGIA 35 0.0002
975 TREATMENT FAILURE 17 0.0002
976 NEUTROPENIA 26 0.0002
977 SKIN BURNING SENSATION 13 0.0002
978 ANAPHYLACTIC REACTION 10 0.0002
979 FEBRILE NEUTROPENIA 12 0.0002
980 BLADDER CANCER 10 0.0002
981 ALOPECIA 32 0.0002
982 DRUG WITHDRAWAL SYNDROME 14 0.0002
983 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
984 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
985 INJECTION SITE BRUISING 10 0.0001
986 INJECTION SITE HAEMORRHAGE 10 0.0001
987 DRUG ABUSE 10 0.0001
988 DRUG DEPENDENCE 18 0.0001
989 RHEUMATOID ARTHRITIS 12 0.0001
990 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
991 INJECTION SITE PAIN 16 0.0001